Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 21, 2021
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
[ Thu, Oct 21st 2021
] - WOPRAI
Wed, October 20, 2021
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
[ Wed, Oct 20th 2021
] - WOPRAI
Tazeen Ahmad Downgraded (ASND) to Hold and Increased Target to $169 on, Oct 20th, 2021
Tazeen Ahmad of B of A Securities, Downgraded "Ascendis Pharma A/S" (ASND) to Hold and Increased Target from $164 to $169 on, Oct 20th, 2021.
Tazeen has made no other calls on ASND in the last 4 months.
There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tazeen
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $204 on, Thursday, August 26th, 2021
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $182 on, Thursday, August 26th, 2021
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $185 on, Thursday, August 26th, 2021
